Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A new study explores the "drusen ooze" hypothesis, revealing how drusen can regress without atrophy in age-related macular ...

In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they had the ability to cure one eye disease or condition in the snap of their ...

A panelist discusses how the iDose implant is surgically placed into the scleral wall with precision, can be repositioned if needed, and remains stable even after procedures like goniotomy, making it ...

A panelist discusses how interventional glaucoma emphasizes early, proactive treatment strategies to reduce IOP and medication burden while addressing patient adherence and long-term disease control.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

OpZira Inc was formed after Alcon acquired LumiThera, with LumiThera's diagnostic products spun off to create the new company ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Alcon has announced its launch of the first fully personalized LASIK treatment, wavelight plus, in the US and Canada. 1 The ...

Timothy Lai, MD, shares promising one-year results from the SALWEEN study on faricimab for polypoidal choroidal vasculopathy ...

An expert discusses how she treated a 70-year-old patient with high myopia with mild glaucoma and cataracts using a light ...

An expert discusses how she managed an unusual case of a patient with high myopia with angle closure and elevated intraocular ...